Emergent Biosolutions Canada INC
UEI XM23STFMVML6 · subsidiary of Emergent Biosolutions INC. · SAM.gov record ↗
$232.6M
FY2025 obligations
2
Contract awards
May 30, 2019
First action
May 26, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$232.6M
Obligations by NAICS
Monthly obligations
Mar 25
Jun 25
Jul 25
Mar 26
May 26
Contracts ending within 18 months (recompete watch)
- 75A50119C00075 ↗$126.9M
EO14042 BOTULISM ANTITOXIN
- Ends
- Mar 29, 2027
- Started
- Sep 29, 2019
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 325412
- 75A50119C00037 ↗$105.6M
VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
- Ends
- Mar 29, 2027
- Started
- May 30, 2019
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 325412
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50119C00075 ↗ | EO14042 BOTULISM ANTITOXIN | Office Of Assistant Secretary For Preparedness And Response | 325412 | $126.9M | Sep 29, 2019 | Mar 29, 2027 |
| 75A50119C00037 ↗ | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS. | Office Of Assistant Secretary For Preparedness And Response | 325412 | $105.6M | May 30, 2019 | Mar 29, 2027 |
Largest awards
- 75A50119C00075 ↗$126.9M
EO14042 BOTULISM ANTITOXIN
- Ends
- Mar 29, 2027
- Started
- Sep 29, 2019
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 325412
- 75A50119C00037 ↗$105.6M
VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS.
- Ends
- Mar 29, 2027
- Started
- May 30, 2019
- Agency
- Office Of Assistant Secretary For Preparedness And Response
- NAICS
- 325412
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50119C00075 ↗ | EO14042 BOTULISM ANTITOXIN | Office Of Assistant Secretary For Preparedness And Response | 325412 | $126.9M | Sep 29, 2019 | Mar 29, 2027 |
| 75A50119C00037 ↗ | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (VIG-IV) BUY AND ASSOCIATED SERVICES FOR UP TO 10 YEARS. | Office Of Assistant Secretary For Preparedness And Response | 325412 | $105.6M | May 30, 2019 | Mar 29, 2027 |